MYTE CEO files Form 144 to sell 274,174 shares; 3-mo sales near 1M

Q: How many MYTE shares does the CEO plan to sell under this Form 144?

The notice covers 274,174 common shares valued at roughly $2.26 million.

Q: When is the planned sale date for the new MYTE share disposal?

The approximate sale date disclosed is July 28, 2025 .

Q: What percentage of MYTE鈥檚 shares outstanding does the proposed sale represent?

About 0.20 % of the 136.4 million shares outstanding.

Q: How many MYTE shares has Michael Kliger already sold in the last 3 months?

He has disposed of approximately 989,862 shares for gross proceeds near $8 million.

Q: Is the CEO鈥檚 trading conducted under a Rule 10b5-1 plan?

Yes. The filing states the sales rely on a pre-arranged 10b5-1 trading plan .

Q: Does the Form 144 include any company earnings or operational updates?

No. The document only relates to planned insider share sales ; it contains no financial performance data.

[144] Pitney Bowes Inc. SEC Filing

Filing Impact

(Low)

Filing Sentiment

(Neutral)

Form Type

144

Rhea-AI Filing Summary

MYT Netherlands Parent B.V. (NYSE: MYTE) 鈥� Form 144 filing discloses additional insider share sales by CEO Michael Kliger.

Proposed sale: 274,174 common shares (鈮�0.20 % of the 136.4 m shares outstanding) through Morgan Stanley; estimated value $2.26 m; anticipated sale date 28 Jul 2025 on the NYSE.
Source of shares: 182,216 shares granted via Phantom Award (20 Jan 2021) and 91,958 RSUs vested 30 Jun 2025.
Prior 3-month activity: Kliger sold about 989,862 shares for total gross proceeds near $8 m under a Rule 10b5-1 program.

The filer certifies no undisclosed adverse information and relies on a pre-arranged trading plan. No operating or earnings data are provided.

Positive

None.

Negative

Nearly 1 million shares sold by the CEO in the past three months, with a new notice to sell 274 k more, may signal reduced insider confidence and create supply overhang.

Insights

TL;DR 鈥� CEO plans to sell 274 k more shares; cumulative insider selling nears 1 m, modest float impact but could weigh on sentiment.

While 274 k shares represent only 0.2 % of shares outstanding, the pattern of almost 1 m shares sold in the last quarter signals sustained insider distribution. Such activity often raises questions about management鈥檚 confidence in near-term upside and can create incremental supply that pressures the stock, especially for a company with limited trading liquidity. Because the sale is executed under a disclosed 10b5-1 plan, it does not necessarily imply negative non-public information, yet the magnitude and cadence of sales are worth monitoring. From a valuation standpoint, no fundamentals change 鈥� the filing is informational rather than operational. Overall impact is neutral to mildly negative due to perception risk rather than financial dilution.

07/28/2025 - 04:19 PM

144: Filer Information

Filer CIK

Filer CCC

Is this a LIVE or TEST Filing?

LIVE TEST

Submission Contact Information

Name

Phone

E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold

Name and Address of the Broker

Number of Shares or Other Units To Be Sold

Aggregate Market Value

Number of Shares or Other Units Outstanding

Approximate Date of Sale

Name the Securities Exchange

Common

Morgan Stanley Smith Barney LLC Executive Financial Services
1 New York Plaza
8th Floor
New York NY 10004

500000

6019600.00

181253371

07/28/2025

NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class

Date you Acquired

Nature of Acquisition Transaction

Name of Person from Whom Acquired

Is this a Gift?

Date Donor Acquired

Amount of Securities Acquired

Date of Payment

Nature of Payment *

Common

07/28/2025

Exercise of options under a registered plan

Issuer

500000

07/28/2025

Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller

Title of Securities Sold

Date of Sale

Amount of Securities Sold

Gross Proceeds